IDTechEx Examines the Opportunities for Wearables in Digital Health
April 19, 2024 | IDTechExEstimated reading time: 3 minutes
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred – medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications as a key focus for their wearable products. IDTechEx’s report, “Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook”, covers this ongoing trend in the consumer health wearables market and includes analysis of the opportunities and roadmap for biometric monitoring.
Consumer devices battle for medical applications
A direction of travel that has been evident in the wearables industry is the increase in health metrics monitored by smartwatches. A key development in February 2024 was the clearance by the US regulatory body, the Food and Drug Administration (FDA), of the Samsung Galaxy Watch app for the assessment of sleep apnea risk. Sleep apnea is a serious sleep disorder that has significant health implications but is often undiagnosed. The ability to detect silent health conditions via a consumer device has the potential to create improvements in quality of life for a significant population of users. Upcoming consumer electronics, particularly new form factors such as smart rings, promise to bring even more health monitoring capabilities.
Underpinning the sleep apnea detection algorithm are optical sensors capable of detecting the wearer’s blood oxygen levels. While the FDA clearance is significant, the truth is that consumers have been able to check their quality of sleep for signs of sleep apnea, including movement, respiratory rate, and blood oxygen, for several years. The key difference is that with FDA clearance, the devices are no longer categorized as “wellness devices”, which come with major warnings that the data generated are not intended for medical use.
Though there are countless biometrics that can be monitored by smartwatches and other consumer electronics, the reality is that there are only a select few medical conditions that have the potential to drive substantial numbers of new users to these products. When compared to existing diagnostics or monitoring methods, consumer electronics companies will need to prove that comfortable and continuous monitoring provides significant benefit over incumbent technologies, for a large enough market.
The IDTechEx report on digital health discusses opportunities for consumer health wearables, including key value propositions and a roadmap for wearable sensor technology segmented by key biometrics. For additional information on the sensor technologies required for key medical applications in consumer electronics, please refer to the IDTechEx research report Wearable Sensors 2023 – 2033.
Medical device companies eye up the consumer market
On the other end of the spectrum, medtech companies have also been entering the consumer market. Some products, such as the Omron HeartGuide blood pressure monitoring smartwatch launched in 2019, have been specifically designed from the ground up as a consumer health wearable.
However, the key health technology that is making the switch to consumer markets comes in the form of an electronic skin patch. Specifically, the continuous glucose monitor, a majorly disruptive piece of health technology in the Type 1 diabetes market, has been increasingly marketed toward consumers in recent years. These began with niche markets, such as elite athletes competing in endurance sports, but have shifted now to people interested in leveraging data on their metabolism to achieve wellness goals.
Currently, Abbott’s Lingo is available in the UK to help consumers better understand their metabolism and to improve their health. In 2024, rival Dexcom received the first FDA approval to sell a CGM over the counter in the US. Called Stelo, the device will be available in the summer of 2024 and marks a major first step into the digital health for pre- and type 2 diabetes markets. IDTechEx’s report on digital health covers the intersection of the digital health, diabetes, and consumer markets and includes a 10-year forecast for the CGM market from 2024 – 2034.
Suggested Items
Arrow Electronics Earns Dual Honors as Dell Technologies Partner of the Year
05/29/2025 | BUSINESS WIREGlobal technology solutions provider Arrow Electronics has received two prestigious awards from Dell Technologies: 2025 OEM Solutions Partner of the Year and 2025 North America Distributor of the Year. The awards were announced at Dell Technologies World, held in Las Vegas in late May.
DuPont Achieves 100% Renewable Electricity Across its European Union Operations
05/28/2025 | DuPontDuPont announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs).
NVIDIA Expected to Launch RTX PRO 6000 Special Edition for China’s AI Market, Potentially Boosting Future GDDR7 Demand
05/28/2025 | TrendForceTrendForce reports that following the new U.S. export restrictions announced in April—which require additional permits for the export of NVIDIA’s H20 or any chips with equivalent memory bandwidth or interconnect performance to China—NVIDIA is expected to release a special low-power, downscaled version of the RTX PRO 6000 (formerly B40) for the Chinese market.
CIMS to Exhibit at JPCA Show 2025
05/28/2025 | CIMSCIMS is excited to announce our participation at JPCA 2025 in Tokyo, Japan! Join us from June 4-6.
Imec Unveils Record-Low Loss 300mm RF Silicon Interposer for Sub-THz Systems
05/27/2025 | ImecAt the IEEE ECTC 2025 conference, imec – a world-leading research and innovation hub in nanoelectronics and digital technologies – highlights the exceptional performance and flexibility of its 300mm RF silicon interposer platform.